Previous close | 1.5700 |
Open | 1.4000 |
Bid | 1.1300 |
Ask | 1.4000 |
Strike | 80.00 |
Expiry date | 2025-01-17 |
Day's range | 1.2700 - 1.4000 |
Contract range | N/A |
Volume | |
Open interest | 3.05k |
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.
Comprehensive Analysis of Gilead's First Quarter Financial Performance